一种新的HIF2A突变导致脂质不良,并促进肝脏脂质的积累
Feiqiong Gao1, Qigu Yao1, Jiaqi Zhu1
1State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Rd., Hangzhou City 310003, China; National Clinical Research Center for Infectious Diseases, Hangzhou City 310003, China.
Pharmacological research
|July 15, 2023
概括
在患有肝脏疾病和脂质失调症的患者中发现了低氧诱导因子-2α (HIF-2α) 的新型突变. 这种HIF-2α突变通过增加脂肪酸的合成和运输,促进了肝脏中的脂质积累.
科学领域:
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
- 肝病学 肝病学是一种肝病学.
背景情况:
- 缺氧诱导因子-2α (HIF-2α) 调节参与血管生成和新陈代谢的基因.
- 在肝病患者中检测到HIF-2α C终端交换活化域 (CTAD) 中的一种新突变 (c.C2473T; p.R825S).
研究的目的:
- 为了研究c.C2473T (p.R825S) HIF-2α突变的功能影响.
- 探索突变在脂质积累和肝脏基因表达中的作用.
主要方法:
- 来自肝脏疾病患者的肝脏和血液样本的测序.
- 创建细胞系和具有HIF-2α突变的转基因小鼠模型.
- 油红色O染色和生物化学测试,以评估脂质积累.
- 对基因转录和蛋白质水平的分析.
主要成果:
- 在5/356名肝病和脂质失调患者中发现了HIF-2α突变.
- 突变的小鼠和细胞表现出高甘油水平和肝脂滴积累.
- 在突变模型中观察到与肝脏脂肪酸运输和合成相关的基因转录增加.
- 核HIF-2α和PLIN2蛋白水平升高,突变群体的脂质消化率下降.
结论:
- 鉴定到的HIF-2α突变与一种特定的血脂不良症亚群相关.
- 这种突变通过改变基因调节和减少脂质消化,促进肝脏脂质积累.
- 研究结果表明,对肝病和脂质失调症个性化治疗策略的潜在影响.
关键词:
胆固醇 (PubChem CID: 5997) 的使用情况德克萨米他 (PubChem CID: 5743) 的使用情况低氧诱导因子-2α.脂质滴滴是什么 脂质滴滴是什么脂质性消化 (Lipophagy) 是一种消化方式.甲醇 (PubChem CID: 887) 是一个突变突变是一种突变.无酒精脂肪肝是一种非酒精性脂肪肝.油脂酸 (PubChem CID: 445639) 的使用情况棕酸 (PubChem CID: 985) 的使用情况佩里利平-2是什么?普罗米辛 (PubChem CID: 439530) 是一种药物.链杆菌素 (PubChem CID: 19649) 是一种药物.
相关概念视频
01:24Overview of Lipid Metabolism
1.8K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.8K
01:25Lipid Catabolism
80
Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...
80
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
702
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
702
01:24Lipid Absorption
536
Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
536